• LAST PRICE
    11.1200
  • TODAY'S CHANGE (%)
    Trending Down-0.2600 (-2.2847%)
  • Bid / Lots
    10.8500/ 6
  • Ask / Lots
    11.7500/ 10
  • Open / Previous Close
    11.2300 / 11.3800
  • Day Range
    Low 10.8500
    High 11.4900
  • 52 Week Range
    Low 8.2500
    High 22.2000
  • Volume
    44,861
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 11.38
TimeVolumeDTIL
09:32 ET60211.23
09:34 ET25811.22
09:41 ET10011.22
09:43 ET20011.22
09:48 ET86711.225
09:52 ET36011.285
10:08 ET30011.34
10:35 ET10011.31
10:39 ET10011.31
11:08 ET13311.35
11:49 ET220011.4
11:51 ET20011.48
11:54 ET46611.39
01:19 ET10011.2601
01:32 ET104711.255
01:33 ET10011.18
01:35 ET20011.15
01:44 ET108211.075
01:46 ET10011
01:57 ET30010.925
02:04 ET10010.86
02:06 ET10910.955
02:11 ET10010.9386
02:26 ET20011
02:27 ET10011.015
02:40 ET13610.9971
02:49 ET20011.25
02:58 ET10011.06
03:14 ET10011.23
03:16 ET11911.1772
03:27 ET20011.19
03:36 ET20011.23
03:38 ET20011.23
03:41 ET2053611.16
03:48 ET10011.12
03:50 ET10010.951
03:52 ET60010.9
03:54 ET159910.97
03:56 ET10011.055
03:57 ET20011.12
03:59 ET30011.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDTIL
Precision BioSciences Inc
78.8M
-2.0x
---
United StatesCSBR
Champions Oncology Inc
70.0M
-7.0x
---
United StatesMEIP
MEI Pharma Inc
19.5M
0.7x
---
United StatesRVLPQ
RVL Pharmaceuticals PLC
110.0
0.0x
---
United StatesRPTX
Repare Therapeutics Inc
166.4M
-3.5x
---
United StatesNEPTF
Neptune Wellness Solutions Inc
101.5K
0.0x
---
As of 2024-06-15

Company Information

Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its proprietary ARCUS genome editing platform. Using ARCUS, the Company's pipeline consists of in vivo gene editing candidates designed to deliver cures for a range of genetic and infectious diseases. The ARCUS platform develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision. ARCUS particularly generates defined outcomes due to predominant repair using homology directed repair (HDR) as opposed to non-homologous end joining (NHEJ). The Company’s in vivo gene editing programs include PBGENE-HBV, PBGENE-PMM, PBGENE-NVS, PBGENE-DMD, PBGENE-LL2, PBGENE-LL3 and iECURE-OTC. PBGENE-HBV program is designed for the potential treatment of chronic hepatitis B virus (HBV). The Company is pursuing development of PBGENE-PMM as a potential opportunity for treatment of m.3243 associated primary mitochondrial myopathy (PMM).

Contact Information

Headquarters
302 E Pettigrew St Ste A100DURHAM, NC, United States 27701-2393
Phone
919-314-5512
Fax
480-393-5553

Executives

Independent Chairman of the Board
Kevin Buehler
President, Chief Executive Officer, Director
Michael Amoroso
Chief Financial Officer
Alex Kelly
General Counsel, Secretary
Dario Scimeca
Chief Medical Officer
Alan List

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$77.0M
Revenue (TTM)
$57.5M
Shares Outstanding
6.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.75
EPS
$-5.50
Book Value
$4.53
P/E Ratio
-2.0x
Price/Sales (TTM)
1.3
Price/Cash Flow (TTM)
---
Operating Margin
-60.09%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.